The positive Her2, unfavorable Ki-67 and p53 means that the tumor has an aggressive character. Aggressive in the sense that it tends to metastasize early and portends to a more unfavorable prognosis. There is a drug called Herceptin that has dramatically improved survival for Her2 + breast cancer patients. It is a monoclonal antibody that specifically targets that Her2 receptor on tumor cells.
Positive ER and PR receptors mean that your tumor is responsive to hormonal stimulation (estrogen and progesterone) and blocking these receptors through drugs like tamoxifen and aromatase inhibitors (arimidex, letrozole, exemestane) should result in better disease control and survival.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.